Evaluation of the cardiac STATus CK-MB/myoglobin card test to diagnose acute myocardial infarctions in the ED

Am J Emerg Med. 1997 May;15(3):303-7. doi: 10.1016/s0735-6757(97)90021-8.

Abstract

A study was undertaken to evaluate a Card Test called "Spectral Diagnostics Inc Cardiac STATus CK-MB/Myoglobin" (Toronto, Canada), which is distributed by Dade International Inc, Miami, FL, for the simultaneous qualitative determination of CK-MB and myoglobin levels in human serum. The Card Test is advertised by the manufacturer as an aid in diagnosing acute myocardial infarction (AMI) in the emergency department (ED). Fifty-eight consecutive serum samples were obtained from 25 patients being evaluated for AMI in an ED. Qualitative CK-MB and myoglobin results from the Card Test were compared with quantitative CK-MB and myoglobin results using the ACS-180 instrument (Ciba Corning Diagnostics, Medfield, MA) and Stratus IIntellect T (Dade International Inc, Miami, FL), respectively. Qualitative results from the STATus CK-MB/Myoglobin Card Test were similar, diagnostically, to quantified results using these automated instruments.

Publication types

  • Clinical Trial
  • Comparative Study

MeSH terms

  • Acute Disease
  • Clinical Laboratory Techniques / methods
  • Confidence Intervals
  • Creatine Kinase / blood*
  • Emergency Service, Hospital
  • Humans
  • Immunoenzyme Techniques*
  • Isoenzymes
  • Myocardial Infarction / blood*
  • Myoglobin / blood*
  • Predictive Value of Tests
  • ROC Curve
  • Sensitivity and Specificity

Substances

  • Isoenzymes
  • Myoglobin
  • Creatine Kinase